Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

PLOD3 is Upregulated in Gastric Cancer and Correlated with Clinicopathologic Characteristics

1 Jan 2019

Abstract excerpt

BACKGROUND: Procollagen-lysine, 2-oxoglutarate 5-dioxygenase 3 (PLOD3) has been proven to be involved in various human cancers; however, the function of PLOD3 in gastric cancer (GC) remains unclear. In this study, the role of PLOD3 in GC was evaluated. METHODS: The expression of PLOD3 in GC tissues and normal tissues was predicted by The Cancer Genome Atlas (TCGA). The kmplot online tool was performed to evaluate...

Topics

Join the communities discussing this publication.

Connective tissue disorders research
Lipid metabolism and disorders
Microbial metabolism and enzyme function

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 30775879
DOI: 10.7754/clin.lab.2018.180541

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

PLOD3 is Upregulated in Gastric Cancer and Correlated with Clinicopathologic CharacteristicsPMID 30775879Read ↗

Integrated Profiling Identifies PLOD3 as a Potential Prognostic and Immunotherapy Relevant Biomarker in Colorectal Cancer.Semantic proximity Read ↗

PLOD2 as a potential regulator of peritoneal dissemination in gastric cancerSemantic proximity Read ↗

A Human Pan-Cancer System Analysis of Procollagen-Lysine, 2-Oxoglutarate 5-Dioxygenase 3 (PLOD3).Semantic proximity Read ↗

The PLOD2 promotes tumor progression in colorectal cancer through the PI3K-AKT pathwaySemantic proximity Read ↗

Oxysterol binding protein-like 3 (OSBPL3) is a novel driver gene that promotes tumor growth in part through R-Ras/Akt signaling in gastric cancerSemantic proximity Read ↗

EDIL3 is a Potential Prognostic Biomarker and Correlates with Immune Infiltrates in Gastric CancerSemantic proximity Read ↗

MBD3 promotes epithelial-mesenchymal transition in gastric cancer cells by upregulating ACTG1 via the PI3K/AKT pathwaySemantic proximity Read ↗

Comprehensive analysis reveals that P4HA3 is a prognostic and diagnostic gastric cancer biomarker that can predict immunotherapy efficacy.Semantic proximity Read ↗

Identification of ALDH3A2 as a novel prognostic biomarker in gastric adenocarcinoma using integrated bioinformatics analysisSemantic proximity Read ↗

MYBL2 promotes cell proliferation and inhibits cell apoptosis via PI3K/AKT and BCL2/BAX/Cleaved-caspase-3 signaling pathway in gastric cancer cellsSemantic proximity Read ↗

Hypomethylation induced overexpression of PLOD3 facilitates colorectal cancer progression through TM9SF4-mediated autophagySemantic proximity Read ↗

PLCD3 inhibits apoptosis and promotes proliferation, invasion and migration in gastric cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.